We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.9B
AUM Growth
+$1.63B
Cap. Flow
-$1.42B
Cap. Flow %
-4.19%
Top 10 Hldgs %
15.42%
Holding
3,077
New
93
Increased
384
Reduced
2,402
Closed
59

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.6M
2
XOM icon
ExxonMobil
XOM
+$33.5M
3
DELL
DELL INC
DELL
+$27.8M
4
GE icon
GE Aerospace
GE
+$22.8M
5
IBM icon
IBM
IBM
+$19M

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Technology 13.93%
3 Healthcare 12.71%
4 Industrials 11.47%
5 Energy 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEYS icon
2626
Weyco Group
WEYS
$392M
$281K ﹤0.01%
9,542
-500
-5% -$14.3K
POZN
2627
DELISTED
POZEN INC
POZN
$281K ﹤0.01%
34,890
-2,400
-6% -$17.1K
CRRC
2628
DELISTED
COURIER CORP
CRRC
$280K ﹤0.01%
15,452
-1,000
-6% -$17.1K
PLUS icon
2629
ePlus
PLUS
$2.53B
$279K ﹤0.01%
19,636
-1,200
-6% -$16.1K
TU icon
2630
Telus
TU
$14.8B
$279K ﹤0.01%
+16,200
New +$279K
ENT
2631
DELISTED
Global Eagle Entertainment Inc.
ENT
$279K ﹤0.01%
751
GBNK
2632
DELISTED
Guaranty Bancorp
GBNK
$279K ﹤0.01%
19,883
-1,300
-6% -$18.1K
ACHN
2633
DELISTED
Achillion Pharmaceuticals
ACHN
$278K ﹤0.01%
83,630
-9,734
-10% -$28.2K
CHTP
2634
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
$278K ﹤0.01%
62,733
MT icon
2635
ArcelorMittal
MT
$56.7B
$277K ﹤0.01%
+6,796
New +$253K
DFRG
2636
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$277K ﹤0.01%
11,754
-500
-4% -$10K
SCLN
2637
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$277K ﹤0.01%
54,862
-1,300
-2% -$6.26K
MPO
2638
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
$277K ﹤0.01%
4,189
-300
-7% -$17.4K
CTG
2639
DELISTED
Computer Task Group, Inc.
CTG
$276K ﹤0.01%
14,627
IMMR icon
2640
Immersion
IMMR
$254M
$274K ﹤0.01%
26,370
-1,700
-6% -$20.8K
FMX icon
2641
Fomento Económico Mexicano
FMX
$43B
$273K ﹤0.01%
+2,790
New +$262K
IX icon
2642
ORIX
IX
$44.1B
$273K ﹤0.01%
+15,300
New +$262K
TCRT icon
2643
Alaunos Therapeutics
TCRT
$4.66M
$273K ﹤0.01%
420
+1
+0.2% +$595
TESS
2644
DELISTED
Tessco Technologies Inc
TESS
$273K ﹤0.01%
6,777
-400
-6% -$15K
CTO
2645
CTO Realty Growth
CTO
$815M
$272K ﹤0.01%
27,593
-1,842
-6% -$18.4K
HGG
2646
DELISTED
hhgregg Inc.
HGG
$272K ﹤0.01%
19,469
-1,200
-6% -$19.2K
SWS
2647
DELISTED
SWS GROUP INC
SWS
$272K ﹤0.01%
44,663
-2,700
-6% -$15.9K
MILL
2648
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
$271K ﹤0.01%
38,481
-2,700
-7% -$20K
CHDX
2649
DELISTED
CHINDEX INTL INC
CHDX
$271K ﹤0.01%
15,538
-600
-4% -$9.88K
OSIR
2650
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$271K ﹤0.01%
16,869

Similar funds

RhumbLine Advisers's Q4 2013 Portfolio in Review

As of Q4 2013, RhumbLine Advisers held 3,077 positions worth $33.9B, up 5% from $32.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.42B in Q4 2013, closing 59 positions and reducing 2,402 holdings. Its most notable exit was NYSE EURONEXT INC, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Transocean worth $12.5M.

  • RhumbLine Advisers's largest Q4 2013 buy was Transocean: 252,714 shares worth $12.5M.
  • RhumbLine Advisers added most to Meta Platforms (Facebook) in Q4 2013, an estimated $50.1M increase.
  • RhumbLine Advisers's biggest Q4 2013 reduction was Apple, cutting an estimated $41.6M.
  • RhumbLine Advisers fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $15.2M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.9B portfolio in Q4 2013.
  • RhumbLine Advisers opened 93 new positions and closed 59 in Q4 2013.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $33.9B.

Based on RhumbLine Advisers's 13F filing for Q4 2013, filed 3 Feb 2014.